The Lighthouse®
Hydroxychloroquine has not been approved by the FDA for COVID-19—leading many to criticize Trump, an advocate for its use. But the FDA has approved hydroxychloroquine as safe for patients with malaria, lupus, and arthritis. Using it for COVID-19 would be off-label, yet about 20 percent of all drug usage in the country is off-label.
READ MORE »
Richard A. Epstein (4/10/20)
The coronavirus crisis raises two urgent questions for the United States. First, what is the likely number of deaths from the coronavirus, in either the absence or presence of social intervention? Second, in light of the limited resources that are available, what is the set of tools, both coercive and noncoercive, that should be used to implement the most effective interventions?
READ MORE »
Richard K. Vedder (Forbes, 4/13/20)
No one knows the precise financial damage that the COVID-19 pandemic will inflict on American colleges and universities—or how much aid stressed federal, state, and local governments will be able, or willing, to deliver to them. One of the likely casualties of this uncertainty? Tenure.
READ MORE »
Gary M. Galles (4/9/20)
Certain medical experts with media megaphones have been putting forward potentially catastrophic scenarios, along with drastic plans to deal with them. However, having medical expertise does not make one an expert on government policy.
READ MORE »
John C. Goodman (Forbes, 4/13/20)
A revolution in the way medical care is delivered in the United States is upon us. Doctors and patients are now communicating by means of phone, email, Skype, Zoom and other devices. If you are like a great many people, you are probably wondering why it took so long.
READ MORE »
The Lighthouse® is the weekly email newsletter of the Independent Institute.
Subscribe now, or browse Back Issues.
Volume 22, Issue 16: April 21, 2020
Ronald L. Trowbridge (The Hill, 4/16/20)
Hydroxychloroquine has not been approved by the FDA for COVID-19—leading many to criticize Trump, an advocate for its use. But the FDA has approved hydroxychloroquine as safe for patients with malaria, lupus, and arthritis. Using it for COVID-19 would be off-label, yet about 20 percent of all drug usage in the country is off-label.
READ MORE »Richard A. Epstein (4/10/20)
The coronavirus crisis raises two urgent questions for the United States. First, what is the likely number of deaths from the coronavirus, in either the absence or presence of social intervention? Second, in light of the limited resources that are available, what is the set of tools, both coercive and noncoercive, that should be used to implement the most effective interventions?
READ MORE »
Crisis and Leviathan
Critical Episodes in the Growth of American Government (25th Anniversary Edition)
Critical Episodes in the Growth of American Government (25th Anniversary Edition)
By Robert Higgs
Richard K. Vedder (Forbes, 4/13/20)
No one knows the precise financial damage that the COVID-19 pandemic will inflict on American colleges and universities—or how much aid stressed federal, state, and local governments will be able, or willing, to deliver to them. One of the likely casualties of this uncertainty? Tenure.
READ MORE »
Gary M. Galles (4/9/20)
Certain medical experts with media megaphones have been putting forward potentially catastrophic scenarios, along with drastic plans to deal with them. However, having medical expertise does not make one an expert on government policy.
READ MORE »
Best Books on the Folly of Socialism
What Everyone Should Know About the Practical and Moral Failures of the Socialist Project
What Everyone Should Know About the Practical and Moral Failures of the Socialist Project
By Williamson M. Evers
John C. Goodman (Forbes, 4/13/20)
A revolution in the way medical care is delivered in the United States is upon us. Doctors and patients are now communicating by means of phone, email, Skype, Zoom and other devices. If you are like a great many people, you are probably wondering why it took so long.
READ MORE »
The Beacon: New Blog Posts
- Coronavirus Relief Blows Up the Federal Budget, by Craig Eyermann
- The Key Indicator for Reopening the Economy Is Hospital Capacity, by Benjamin Powell
- Economy Prosperity or Pandemic Protection: Why Not Both?, by Raymond J. March
- No President Has “Total Power” over States’ Plans to Reopen, by William J. Watkins Jr.
Catalyst: New Articles
- Infection Surveillance in the Name of Public Health, by Jonathan Hofer
- Make American Colleges Grade Again!, by Richard K. Vedder
- Towards a Free-Market for Curb Space, by Scott Beyer
